HAP Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

HAP Trading’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20,417	Closed	-$5K	–	1210
2018 Q3	$5K	Sell	20,417 -304,232	-94%	-$4.81M	﹤0.01%	903
2018 Q2	$632K	Buy	+324,649	New	+$4.8M	0.03%	299

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

HAP Trading's IRWD Position: Q4 2021 in Review

HAP Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 21,611 shares — an estimated $282K sold.

HAP Trading first reported a position in IRWD in Q4 2018 and held it in 3 quarters. The position peaked at $282K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

HAP Trading reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 21,611 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $282K.
HAP Trading first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 3 quarters.
HAP Trading's Ironwood Pharmaceuticals position peaked at $282K in Q3 2021.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.